Description

KSPWFTTL is an immunodominant Kb-restricted epitope from the p15E transmembrane protein. KSPWFTTL can restore susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes[1][2].—COVID-19-anti-virus–C48H70N10O12—-[1]White HD, et, al. An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes. J Virol. 1994 Feb;68(2):897-904.|[2]Rich RF, et, al. Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells. J Virol. 1999 May;73(5):3826-34.–153049-05-9–979.13—-O=C([C@H]1N(CCC1)C([C@H](CO)NC([C@@H](N)CCCCN)=O)=O)N[C@H](C(N[C@H](C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@H](O)C)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)CC2=CC=CC=C2)=O)CC3=CNC4=CC=CC=C34–Cancer; Inflammation/Immunology–H2O–Others—-Others–Peptides